New cancer clinical trial: Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients

Published on: February 04, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share